Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
Empirical Formula (Hill Notation):
C14H20O5S
CAS Number:
Molecular Weight:
300.37
UNSPSC Code:
12352201
NACRES:
NA.25
PubChem Substance ID:
MDL number:
Beilstein/REAXYS Number:
20033
Quality Level
assay
≥98% (TLC)
form
powder
optical activity
[α]/D -33.00 to -27.00°, c = 9.00-11.00 mg/mL in methanol
technique(s)
thin layer chromatography (TLC): suitable
color
white
solubility
methanol: 49.00-51.00 mg/mL, clear, colorless
storage temp.
2-8°C
SMILES string
OC[C@H]1O[C@@H](SCCc2ccccc2)[C@H](O)[C@@H](O)[C@H]1O
InChI
1S/C14H20O5S/c15-8-10-11(16)12(17)13(18)14(19-10)20-7-6-9-4-2-1-3-5-9/h1-5,10-18H,6-8H2/t10-,11+,12+,13-,14+/m1/s1
InChI key
ZNAMMSOYKPMPGC-HTOAHKCRSA-N
General description
2-Phenylethyl β-D-thiogalactoside is a cell-permable inhibitor of the reporter enzyme β-galactosidase.
Application
2-Phenylethyl β-D-thiogalactoside has been used in a study to assess subnanoliter enzymatic assays on microarrays. It has also been used in a study that investigated the integration of on-column immobilized enzyme reactor in microchip electrophoresis.
Other Notes
To gain a comprehensive understanding of our extensive range of Monosaccharides for your research, we encourage you to visit our Carbohydrates Category page.
Storage Class
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves, type N95 (US)
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Kyung-Han Lee et al.
European journal of nuclear medicine and molecular imaging, 31(3), 433-438 (2004-01-28)
There has recently been increasing interest in the development of radioprobes that specifically target proteins transcribed from expression of reporter genes of interest. The purpose of this study was to develop a radioprobe that targets one of the most widely
Todd Galbraith et al.
Biotechnology journal, 14(1), e1800306-e1800306 (2018-11-30)
There is a strong clinical need to develop small-caliber tissue-engineered blood vessels for arterial bypass surgeries. Such substitutes can be engineered using the self-assembly approach in which cells produce their own extracellular matrix (ECM), creating a robust vessel without exogenous
Pranav R H Joshi et al.
Molecular therapy. Methods & clinical development, 13, 279-289 (2019-03-20)
Despite numerous advancements in production protocols, manufacturing AAV to meet exceptionally high demand (1016-1017 viral genomes [VGs]) in late clinical stages and for eventual systemic delivery poses significant challenges. Here, we report an efficient, simple, scalable, robust AAV5 production process
Global Trade Item Number
| SKU | GTIN |
|---|---|
| P4902-1G | 04061826061534 |
| P4902-250MG | 04061832392493 |
| P4902-50MG | 04061832392509 |